Last updated: 2026-09-04 15:41:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Lisata Therapeutics, Inc. (LSTA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1,65, with a market capitalization of $14,15M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,99 to $5,07. This page covers its latest market performance, valuation, price trends and company information.
$14,15M | |
$1,58 | |
$9,38 | |
$0,99 | |
$1,64 | |
21,81K | |
-- | |
-- | |
$5,07 | |
$0,99 | |
-- | |
-- |
Lisata Therapeutics, Inc. (LSTA) is currently trading at $1,65 as of 2026-09-04 15:33:00, up 0,61% ($0,01) from the previous close of $1,64
During today's regular trading session, LSTA has traded between $0,99 and $9,38, with a trading volume of 21,81K shares. The current price is near the lower end of today's range.
Over the past seven days, Lisata Therapeutics, Inc. (LSTA) moved from $1,66 to $1,65, representing a decline of 0,60% ($0,01).
The stock traded between $1,58 and $1,67 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.
The average daily volume was 190,64 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 16,2%
LSTA is currently trading at $1,65, placing it 16,2% of the way from its 52-week low of $0,99 to its 52-week high of $5,07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 21 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Lisata Therapeutics, Inc. (LSTA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.